Tevapharm India Private Limited - Company Profile

It is a pharma foreign private limited company based in Mumbai, Maharashtra, India, established in 2000.

2000 Mumbai, Maharashtra, India Active

Last Updated: January 05, 2026

About Tevapharm India Private Limited

Tevapharm India Private Limited, a active foreign private limited company, was established on 01 December 2000 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33111MH2000FTC326700. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹700.00 Cr and a paid-up capital of ₹220.19 Cr.

Formerly known as Ratiopharm India Private Limited. It upholds a compliant status. Employing 973 professional, Its leadership includes Nishank Bhargava (Director), Pooja Singh (Additional Director), Vinod Narayan Shetty (Director). Past directors included Matthias Eschricht, Eyal Arieli, Eran Katz. Its latest AGM occurred on 01 September 2025, with the balance sheet filed on 31 March 2025. It is based at 8Th Floor, Tower C, Times Square Andheri Kurla Road, Gamdevi, Marol, Andh, Eri East, Mumbai, Maharashtra, 400059.

Company Details

CIN/LLPIN
U33111MH2000FTC326700
Registration Number
326700
Incorporation Date
01 December 2000
Authorized Capital
₹700.00 Cr
Paid-Up Capital
₹220.19 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 700.00 Cr as on 05-01-2026
Paid Up Capital ₹ 220.19 Cr as on 05-01-2026
Company Age 25 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** -16.32% (FY 2023)
Profit Growth **** 29.00% (FY 2023)
Ebitda **** -22.89% (FY 2023)
Net Worth -6.56% (FY 2023)
Total Assets **** 2.50% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Tevapharm India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Tevapharm India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Nishank Bhargava	Director	24 Feb 2022	Current
Pooja Singh	Additional Director	03 Jun 2025	Current
Vinod Narayan Shetty	Director	24 Aug 2021	Current
Gubbi Channappa Roopa	Director	27 Jun 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	13 Dec 2010	Past
Pramod Abcsdd	Director	13 Feb 2015	Past
Pramod Abcsdd	Additional Director	27 Jun 2012	Past
Pramod Abcsdd	Additional Director	28 Jun 2013	Past
Pramod Abcsdd	Whole-Time Director	29 Sep 2015	Past
Pramod Abcsdd	Additional Director	28 Sep 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tevapharm India.

Tevapharm India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.32% decrease. The company also saw a substantial improvement in profitability, with a 29% increase in profit. The company's net worth dipped by a decrease of 6.56%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-16.32%

*******

Revenue from Operations

*******

-20.86%

*******

Total Assets

*******

2.50%

*******

Profit or Loss

*******

29.00%

*******

Net Worth

*******

-6.56%

*******

EBITDA

*******

-22.89%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tevapharm India?

In 2023, Tevapharm India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Tevapharm India?

Tevapharm India has a workforce of 973 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Tevapharm India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tevapharm India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tevapharm India

Recent Activity within the Organization

Annual General Meeting

Tevapharm India Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records. was recorded as a recent event.
01 Sep 2025
Director Appointment

The activity Komal Manoj Chotrani was appointed as a Company Secretary was appointed as a Company Secretary on 28 Aug 2025 & has been associated with this company since 5 months 14 days . was completed.
28 Aug 2025
Director Appointment

The activity Pooja Singh was appointed as a Additional Director was appointed as a Additional Director on 03 Jun 2025 & has been associated with this company since 8 months 8 days . was completed.
03 Jun 2025
Balance Sheet

Tevapharm India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

Progress on Gubbi Channappa Roopa was appointed as a Director was appointed as a Director on 27 Jun 2024 & has been associated with this company since 1 year 7 months . was documented.
27 Jun 2024
Director Appointment

The activity Nishank Bhargava was appointed as a Director was appointed as a Director on 24 Feb 2022 & has been associated with this company since 3 years 11 months . was completed.
24 Feb 2022

Explore recent activity and updates - View Recent Activity